GBR-1342 is a human bispecific antibody targeting CD38 and CD3. It inhibits the activity of cancer cell lines Daudi, RAJI, RPMI8226, IM-9, and NCI-H929, and is applicable to multiple myeloma research.
Target:
CD38
* VAT and and shipping costs not included. Errors and price changes excepted